Monday May 29, 2017 03:18

Food and Healthcare Press Releases

CLJI Worldwide Trial Enrolls First Patient in Clinical Study Evaluating the Performance of VIBLOK Heathcare—23 May 17

CLJI Worldwide Sponsored Study Assessing the Safety and Performance of VIBLOK in HSV-2 infected adults as a barrier for virus transmission; Principal Investigators Named; First Patient Enrolled CLJI Worldwide reports the start of the VIBLOK Safety And

Leica Biosystems Aperio Digital Pathology Now Nationwide Standard of Care in Heathcare—23 May 17

Leica Biosystems announced today that it has struck a key partnership with the Kuwait Ministry of Health, through its distributor, Technical Services Supplies Trading & Contracting Company, W.L.L. The Pathology Council of Kuwait will now adopt Leica

#Its not you. Its your thyroid. Campaign Launched to Raise Awareness of Heathcare—22 May 17

The information contained in this release is not appropriate for audiences in the USA and Canada. - International survey reveals that almost a third of women could not explain what thyroid disorders are - Most respondents were unaware that symptoms

100 Healthy Years Are Kids Prepared? Heathcare—19 May 17

- Merck Consumer Health's Annual Debate: global expert discussion on how to prepare children to live 100 healthy years - Global study of the Economist Intelligence Unit: today's children will be less healthy than today's adults over 65 when they reach

Healthcare Industry Springs to Life at the World#s Largest Healthcare Event - The Health Industry Heathcare—19 May 17

The Health Industry Summit (tHIS) 2017 hosted by China and organized by Reed Sinopharm, opened in Shanghai at the National Exhibition and Convention Center on May 15th with hundreds of thousands of healthcare industry professionals from more than 150

American Society of Clinical Oncology (ASCO) Publishes Abstract of SIRveNIB, an Investigator-led Heathcare—19 May 17

The SIRveNIB abstract published on-line in the Journal of Clinical Oncology states that treatment of locally advanced Hepatocellular Carcinoma (HCC) with a single treatment of SIR-Spheres(R) Y-90 resin microspheres results in Overall Survival not

Biologique Recherche and Wellness for Cancer are Bringing Face and Body Treatments to Cancer Heathcare—19 May 17

Biologique Recherche has partnered with Wellness for Cancer to adapt facial and body treatments specifically to the needs of cancer patients and those in remission. Treatments will be available in the US and France in June, with plans to expand in over

Shaping Cancer Care Today and Tomorrow: Merck to Present New Data from Rapidly Evolving Pipeline at Heathcare—18 May 17

M7824 (anti-PD-L1/TGF-ss trap): 3006; Avelumab: 9086, 9530, 9557, 4528, 3059, 5037, e21070, e21065, e20581; Tepotinib: 4087, 8547, e15676, 20541; M3814 (DNA-PK): 2556, e14048; M7583 (BTKi): e14101 - ASCO data highlights Merck's strong and rapidly

Merck and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO Heathcare—18 May 17

- A total of 13 abstracts across seven hard-to-treat cancers highlight the progress of avelumab as a monotherapy and potential novel combination treatment option - New data in metastatic Merkel cell carcinoma and previously treated metastatic urothelial

Merck#s Glucophage(R) SR Receives Label Extension for Patients at High Risk of Type 2 Diabetes in Heathcare—18 May 17

- Glucophage(R) SR offers UK healthcare professionals the first licensed treatment option for overweight adult patients at high risk of progression to type 2 diabetes, after failure of intensive lifestyle changes - Non-diabetic hyperglycemia, also known

Early Response to Saxenda(R) Resulted in Weight Maintenance and Additional Weight Loss Over 56 Heathcare—18 May 17

Today, results from a post hoc analysis of data from the SCALE Maintenance trial were presented at the 24th European Congress on Obesity (ECO) 2017. In the trial, adults who lost at least 5% of their initial weight during a low- calorie run-in period

Merck Develops Alternative CRISPR Genome Editing Method Heathcare—18 May 17

- Creates method to rapidly deploy newly discovered bacterial CRISPR systems in disease-specific applications - Research published in prestigious journal, Nature Communications Merck , a leading science and technology company, has developed a new

Inaugural World Preeclampsia Day Spotlights Global Impact on Maternal and Infant Heathcare—12 May 17

Nearly 76,000 mothers and 500,000 babies worldwide lose their lives to preeclampsia and related hypertensive disorders of pregnancy every year. To raise awareness of preeclampsia as a life-threatening complication of pregnancy, maternal health

Leica Biosystems Applauds FDA Primary Diagnosis Clearance as a Step Forward in Clinical Acceptance Heathcare—11 May 17

The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging (WSI) system (Philips IntelliSite(TM) Pathology Solution) for review of digital surgical pathology slides. Leica Biosystems congratulates both

European Commission Grants Approval for Merck#s New Pergoveris(R) Pen for Fertility Heathcare—11 May 17

- With this approval, Pergoveris(R) becomes the first product with a combination of FSH and LH hormones in a ready-to-use liquid version - The new pre-filled injection device for self-administration increases ease-of-use for patients compared to the

FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Heathcare—11 May 17

Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has approved BAVENCIO(R) (avelumab) Injection for the treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) who have disease

ESPGHAN: Consumers Misled by Gluten-free Foods, Study Finds Heathcare—11 May 17

Gluten-free products cannot be considered as sufficient substitutes for their gluten-containing counterparts, prompting scientists to call for the reformulation of gluten free foods with healthier raw materials to ensure healthy childhood nutrition. The


Zuellig Pharma, the region's leading healthcare services provider, has today announced it has invested in Health Benefit Consultants Company (HBC) through its Malaysian subsidiary – MiCare Sdn Bhd. HBC is a leading third party administrator in

Sonova Opens Global Hearing Institute in China Heathcare—09 May 17

Sonova officially opened its first Audiology Training Center in Suzhou, Jiangsu Province, China. The Sonova Global Hearing Institute is a state of the art training center for current and future hearing care professionals. The Hearing Institute has been

Norgine Presents New Post-hoc Data Analyses Highlighting the Efficacy of PLENVU(R) for Bowel Heathcare—08 May 17

Norgine B.V. today presented new post-hoc analyses from the phase III DAYB and MORA studies that demonstrate the high-quality cleansing efficacy of PLENVU(R), a low volume, 1 litre PEG and ascorbate bowel preparation when compared to sodium picosulfate

NSF International Launches Raised Without Antibiotics Certification Heathcare—03 May 17

- Betagro Group in Thailand is first to earn new, independent certification from global public health organization Global public health organization NSF International has developed an independent certification protocol — Raised Without Antibiotics

Terumo BCT Announces 2016 Advancing Apheresis Award Opens Applications for Heathcare—02 May 17

Terumo BCT funds a $10,000 USD grant to Aarhus University Hospital for solving venous access challenges Terumo BCT, a global medical device manufacturing company, announced today that a team from the Aarhus University Hospital (AUH) in Denmark led by

Venus Medtech#s TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In Heathcare—02 May 17

Venus Medtech (Hangzhou) Inc., announced on April 25th that its transcatheter aortic valve system - Venus A-valve - has been approved by China Food and Drug Administration ("CFDA") (registration no.: 20173460680) for sale in China. This marks the


Recently, Maynica Sachdev (center), Fund Raising Manager of Queen Sirikit Centre for Breast Cancer Foundation (QSCBCF), Suttirat Satayaprasert(the 2nd from the left) and Chonnikarn Seritanondh (the 2nd from the right), Lecturers from Albert Laurence